To gain an understanding of the nature of molecular program of BCR::ABL1+ vs. BCR::ABL1- primitive cells, we analyzed differentially expressed genes between the pooled primitive BCR::ABL1+ and BCR::ABL1- populations from all CML patients. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.